CIMC Unveils New Global Brand Logo and Visual Identity System
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- On December 5, 2025, China International Marine Containers (Group) Co., Ltd. (CIMC) unveiled its new brand logo and visual identity system to a global audience. Marking the company's most significant...
Agoda Unveils 2026 Travel Outlook Report: Key Trends for Industry Partners to Capitalize on the Year Ahead
With interest in secondary destinations on the rise, expanding infrastructure and growing access to technology, opportunities await the industry in 2026 SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- Digital travel platform Agoda unveils its 2026 Travel...
Traveloka and Singapore Tourism Board launch regional campaign to inspire spontaneous weekend getaways to Singapore
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- Traveloka, Southeast Asia's leading travel platform, and the Singapore Tourism Board (STB) strengthen their partnership with the launch of a new regional marketing campaign targeting young travellers titled 'A...
Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale
Fares as Low as HKD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/ -- Cebu Pacific (PSE: CEB), the Philippines' leading carrier, spreads holiday cheer early as it unwraps its 12.12 Super Seat Fest, giving travelers the chance to treat themselves...
Inspur Showcases Modular Construction Capability in Brisbane as Demand for Faster, Scalable Delivery Grows
Industry Leaders Examine Compliance Pathways, AI-Enabled Delivery Models, and Practical Strategies for Deploying Modular Projects Across Australia BRISBANE, Australia, Dec. 8, 2025 /PRNewswire/ -- On December 5, 2025, Shandong Inspur Intelligent...
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 8, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company",...
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell...
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...